Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lassale

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapie|September 18, 2014
Telemedicine: what framework, what levels of proof, implementation rulesFaiez Zannad, Philippe Maugendre, Antoine Audry, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Therapie|August 29, 2013
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapie|September 18, 2014
Telemedicine: what framework, what levels of proof, implementation rulesFaiez Zannad, Philippe Maugendre, Antoine Audry, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
[Not Available]Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Therapie|August 29, 2013
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Pageof 2